Tenax Therapeutics (TENX) Short Interest Ratio & Short Volume $5.96 +0.22 (+3.83%) As of 02:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tenax Therapeutics Short Interest DataTenax Therapeutics (TENX) has a short interest of 311,400 shares, representing 8.58% of the float (the number of shares available for trading by the public). This marks a 0.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 14.6, indicating that it would take 14.6 days of the average trading volume of 160,917 shares to cover all short positions.Current Short Interest311,400 sharesPrevious Short Interest310,500 sharesChange Vs. Previous Month+0.29%Dollar Volume Sold Short$1.77 millionShort Interest Ratio14.6 Days to CoverLast Record DateJune 15, 2025Outstanding Shares4,150,000 sharesFloat Size3,630,000 sharesShort Percent of Float8.58%Today's Trading Volume5,974 sharesAverage Trading Volume160,917 sharesToday's Volume Vs. Average4% Short Selling Tenax Therapeutics? Sign up to receive the latest short interest report for Tenax Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTENX Short Interest Over TimeTENX Days to Cover Over TimeTENX Percentage of Float Shorted Over Time Tenax Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025311,400 shares $1.77 million +0.3%8.6%14.6 $5.70 5/31/2025310,500 shares $1.94 million +0.1%8.6%19.3 $6.25 5/15/2025310,300 shares $1.77 million +0.7%8.6%13.3 $5.70 4/30/2025308,300 shares $1.78 million -8.3%8.5%9.3 $5.76 4/15/2025336,100 shares $1.87 million -7.8%9.3%9.2 $5.55 3/31/2025364,400 shares $2.39 million -2.4%10.5%9.4 $6.55 3/15/2025373,500 shares $2.39 million -2.2%11.3%8.7 $6.41 2/28/2025381,700 shares $2.27 million -9.0%11.5%7.8 $5.96 2/15/2025419,500 shares $3.02 million +93.1%14.1%8.4 $7.20 1/31/2025217,200 shares $1.30 million -2.6%7.3%3.9 $6.00 Get the Latest News and Ratings for TENX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025222,900 shares $1.44 million +2.2%7.5%3.5 $6.48 12/31/2024218,200 shares $1.35 million +6.7%7.3%3.3 $6.19 12/15/2024204,500 shares $1.20 million +56.6%6.9%3.3 $5.88 11/30/2024130,600 shares $700.02 thousand +8.0%4.4%2 $5.36 11/15/2024120,900 shares $588.78 thousand +14.3%4.1%2.3 $4.87 10/31/2024105,800 shares $464.46 thousand +403.8%3.6%1.9 $4.39 10/15/202421,000 shares $77.49 thousand -27.8%0.7%0 $3.69 9/30/202429,100 shares $100.69 thousand -42.2%1.0%0.1 $3.46 9/15/202450,300 shares $191.64 thousand -44.7%1.7%0.1 $3.81 8/31/202490,900 shares $362.69 thousand -21.6%3.1%0.2 $3.99 8/15/2024115,900 shares $463.60 thousand +1,014.4%4.6%0.2 $4.00 7/31/202410,400 shares $35.36 thousand -56.7%0.6%0 $3.40 7/15/202424,000 shares $80.64 thousand +103.4%1.3%1 $3.36 6/30/202411,800 shares $35.57 thousand +19.2%0.6%0.5 $3.01 6/15/20249,900 shares $31.09 thousand +54.7%0.5%0.3 $3.14 5/31/20246,400 shares $22.14 thousand -34.7%0.3%0.2 $3.46 5/15/20249,800 shares $35.18 thousand -56.3%0.5%0.1 $3.59 4/30/202422,400 shares $87.36 thousand -36.4%1.2%0.1 $3.90 4/15/202435,200 shares $126.90 thousand -28.2%1.9%0.1 $3.61 3/31/202449,000 shares $207.76 thousand +33.5%2.6%0.1 $4.24 3/15/202436,700 shares $137.63 thousand -49.4%2.2%0.1 $3.75 2/29/202472,500 shares $332.78 thousand +56.3%4.3%0.2 $4.59 2/15/202446,400 shares $194.42 thousand +30.7%2.8%0.2 $4.19 1/31/202435,500 shares $452.63 thousand +153.6%12.2%0.1 $12.75 1/15/202414,000 shares $199.36 thousand +833.3%4.8%0.2 $14.24 12/31/20231,500 shares $32.95 thousand -99.0%0.5%0 $21.97 12/15/2023155,600 shares $40.36 thousand -76.1%N/A0 $0.26 11/30/2023651,100 shares $227.23 thousand -78.1%N/A0.1 $0.35 11/15/20232,970,000 shares $1.48 million +16,308.8%N/A0.4 $0.50 10/31/202318,100 shares $3.36 thousand +43.7%N/A0 $0.19Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 10/15/202312,600 shares $3.97 thousand -84.9%N/A0 $0.32 9/30/202383,200 shares $24.88 thousand +263.3%N/A0.2 $0.30 9/15/202322,900 shares $7.79 thousand +114.0%N/A0 $0.34 8/31/202310,700 shares $3.74 thousand -69.4%N/A0 $0.35 8/15/202335,000 shares $10.49 thousand +1.2%N/A0 $0.30 7/31/202334,600 shares $10.90 thousand -73.7%N/A0 $0.32 7/15/2023131,400 shares $40.34 thousand -74.4%N/A0.2 $0.31 6/30/2023513,000 shares $153.90 thousand -10.3%N/A0.7 $0.30 6/15/2023572,000 shares $165.88 thousand +526.5%N/A0.6 $0.29 5/31/202391,300 shares $33.11 thousand -48.6%1.1%0 $0.36 5/15/2023177,600 shares $58.96 thousand -1.3%2.0%0.1 $0.33 4/30/2023179,900 shares $58.11 thousand -9.5%2.1%0.1 $0.32 4/15/2023198,800 shares $72.96 thousand -13.6%2.3%0 $0.37 3/31/2023230,000 shares $106.95 thousand -89.4%2.6%0.1 $0.47 3/15/20232,160,000 shares $1.23 million +387.7%24.8%0.6 $0.57 2/28/2023442,900 shares $301.17 thousand +21.9%6.3%0.2 $0.68 2/15/2023363,400 shares $339.74 thousand +306.9%5.2%0.4 $0.93 1/31/202389,300 shares $189.32 thousand -12.7%4.8%0.1 $2.12 1/15/2023102,300 shares $241.43 thousand +209.1%5.5%0.3 $2.36 12/30/202233,100 shares $3.69 thousand -94.4%1.8%0.1 $0.11 12/15/2022593,200 shares $78.24 thousand -57.9%N/A0.1 $0.13 11/30/20221,410,000 shares $208.68 thousand +260.4%N/A0.3 $0.15 11/15/2022391,200 shares $52.85 thousand +96.3%N/A0.1 $0.14 10/31/2022199,300 shares $26.29 thousand -4.4%17.2%0.1 $0.13 10/15/2022208,500 shares $30.96 thousand +43.4%18.0%0.4 $0.15 9/30/2022145,400 shares $24.72 thousand +146.0%12.5%0.3 $0.17 9/15/202259,100 shares $15.37 thousand -10.3%5.1%0.1 $0.26 8/31/202265,900 shares $15.75 thousand +1,120.4%5.7%0.3 $0.24 8/15/20225,400 shares $1.58 thousand -93.2%0.5%0 $0.29 7/31/202279,300 shares $20.94 thousand +539.5%6.8%0.4 $0.26 7/15/202212,400 shares $3.26 thousand -94.4%1.1%0.1 $0.26 6/30/2022222,600 shares $66.78 thousand +1,680.8%19.2%1.7 $0.30 6/15/202212,500 shares $7.63 thousand +5.0%1.1%0.1 $0.61 5/31/202211,900 shares $7.85 thousand -51.6%N/A0.4 $0.66 5/15/202224,600 shares $13.97 thousand +7.4%N/A0.7 $0.57 4/30/202222,900 shares $16.64 thousand -45.4%N/A0.6 $0.73 4/15/202241,900 shares $29.76 thousand +37.8%N/A0.9 $0.71 3/31/202230,400 shares $24.61 thousand -7.6%N/A0.5 $0.81 3/15/202232,900 shares $17.44 thousand +75.9%N/A0.2 $0.53 2/28/202218,700 shares $10.99 thousand -50.1%N/A0.1 $0.59 2/15/202237,500 shares $25.84 thousand -11.1%N/A0.2 $0.69 1/31/202242,200 shares $27.43 thousand -39.9%N/A0.3 $0.65 1/15/202270,200 shares $54.39 thousand -39.4%N/A0.4 $0.77 12/31/2021115,900 shares $120.54 thousand -25.9%N/A0.8 $1.04 12/15/2021156,300 shares $179.75 thousand -17.9%N/A1.9 $1.15 11/30/2021190,300 shares $243.58 thousand -25.7%N/A1.5 $1.28 11/15/2021256,100 shares $355.98 thousand -2.9%N/A2.1 $1.39 10/29/2021263,600 shares $400.67 thousand -13.2%N/A2.2 $1.52 10/15/2021303,800 shares $525.57 thousand +29.5%N/A2.5 $1.73 9/30/2021234,600 shares $415.24 thousand +32.2%N/A2 $1.77Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 9/15/2021177,400 shares $244.81 thousand +20.0%N/A1.5 $1.38 8/31/2021147,800 shares $235.00 thousand -0.5%N/A1.3 $1.59 8/13/2021148,500 shares $233.15 thousand -8.7%N/A1.2 $1.57 7/30/2021162,700 shares $281.47 thousand -23.2%1.5%1.3 $1.73 7/15/2021211,900 shares $398.37 thousand +12.2%2.0%1.5 $1.88 6/30/2021188,900 shares $392.91 thousand +14.6%2.9%0.9 $2.08 6/15/2021164,800 shares $342.78 thousand -8.1%2.6%0.1 $2.08 5/28/2021179,400 shares $349.83 thousand -32.0%1.3%0.1 $1.95 5/14/2021263,700 shares $530.04 thousand -31.6%N/A0.2 $2.01 4/30/2021385,700 shares $752.12 thousand -50.8%N/A0.3 $1.95 4/15/2021783,300 shares $1.59 million +64.9%N/A0.5 $2.03 3/31/2021475,100 shares $897.94 thousand -1.3%N/A0.2 $1.89 3/15/2021481,400 shares $1.07 million -15.5%N/A0.1 $2.22 2/26/2021569,400 shares $1.27 million -1.2%N/A0.1 $2.23 2/12/2021576,100 shares $1.61 million -10.0%N/A0.1 $2.79 1/29/2021640,100 shares $1.47 million +325.9%N/A0.1 $2.30 1/15/2021150,300 shares $267.53 thousand -95.9%N/A0 $1.78 12/31/20203,630,000 shares $7.19 million +12,331.5%N/A0.9 $1.98 12/15/202029,200 shares $31.83 thousand -13.9%N/A0.2 $1.09 11/30/202033,900 shares $37.96 thousand +27.0%N/A0.2 $1.12 11/15/202026,700 shares $28.87 thousand -65.3%N/A0.1 $1.08 10/30/202077,000 shares $85.47 thousand -52.1%N/A0.4 $1.11 10/15/2020160,700 shares $199.27 thousand -28.0%N/A0.7 $1.24 9/30/2020223,300 shares $343.88 thousand +58.4%N/A0.7 $1.54 9/15/2020141,000 shares $229.83 thousand -18.8%N/A0.4 $1.63 8/31/2020173,600 shares $248.25 thousand +60.0%N/A0.5 $1.43 8/14/2020108,500 shares $138.88 thousand +83.3%N/A0.1 $1.28 7/31/202059,200 shares $78.74 thousand +187.4%N/A0 $1.33 7/15/202020,600 shares $20.19 thousand -96.7%N/A0 $0.98 TENX Short Interest - Frequently Asked Questions What is Tenax Therapeutics' current short interest? Short interest is the volume of Tenax Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 311,400 shares of TENX short. 8.58% of Tenax Therapeutics' shares are currently sold short. Learn More on Tenax Therapeutics' current short interest. What is a good short interest ratio for Tenax Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TENX shares currently have a short interest ratio of 15.0. Learn More on Tenax Therapeutics's short interest ratio. What is a good short interest percentage for Tenax Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.58% of Tenax Therapeutics' floating shares are currently sold short. Is Tenax Therapeutics' short interest increasing or decreasing? Tenax Therapeutics saw a increase in short interest in June. As of June 15th, there was short interest totaling 311,400 shares, an increase of 0.3% from the previous total of 310,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tenax Therapeutics' float size? Tenax Therapeutics currently has issued a total of 4,150,000 shares. Some of Tenax Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenax Therapeutics currently has a public float of 3,630,000 shares. How does Tenax Therapeutics' short interest compare to its competitors? 8.58% of Tenax Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tenax Therapeutics: Tenaya Therapeutics, Inc. (8.86%), Zentalis Pharmaceuticals, Inc. (8.08%), HilleVax, Inc. (7.11%), Immuneering Corporation (3.45%), Coya Therapeutics, Inc. (1.68%), Cabaletta Bio, Inc. (14.37%), OncoCyte Corporation (1.32%), Milestone Pharmaceuticals Inc. (4.67%), Entera Bio Ltd. (0.18%), Adagene Inc. Sponsored ADR (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Tenax Therapeutics stock? Short selling TENX is an investing strategy that aims to generate trading profit from Tenax Therapeutics as its price is falling. TENX shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tenax Therapeutics? A short squeeze for Tenax Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TENX, which in turn drives the price of the stock up even further. How often is Tenax Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TENX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies TNYA Short Interest Data ZNTL Short Interest Data HLVX Short Interest Data IMRX Short Interest Data COYA Short Interest Data CABA Short Interest Data OCX Short Interest Data MIST Short Interest Data ENTX Short Interest Data ADAG Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TENX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
